Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, many head-scratching coincidences. If you believe in coincidence.
Well, it is certainly set up chart-wise. No more gaps to fill anywhere. Trend reversal on last downward move. Strong hammer. If we ever got buying volume like we did in December we'd be at $2 this week. That said, LP could crush that dream again with an 8K tonight.
People who have never been in my kitchen?
The previous hammer I think you mean was the day after we hit $2.50? Not a hammer in the true sense, body of candlestick is larger than if we close at $1.40 today on this hammer. And, a hammer with little to no body at the bottom of a trend is a reversal signal. The bigger the and more defined the hammer is, the bigger the move....usually.
Could be that the next news we see if an 8k with financing and this was just poor timing on a down day to get rid of the shares and retain the warrants, again.
Agreed. There is simply ZERO confidence with ZERO knowledge of where we are in the process. Many presumed a leak of negative news. Really? In a down market, I don't think so. I think there were sellers following sellers, as usual. We have been teetering on the verge of a correction for weeks. ANYTHING from the company would have prevented this. Sawston, Flaskworks, BLA submitted, UK specials acknowledgement production. I have been waiting for this binary event for over 6 years.
Looks like it's going to be a tough day to hold the 100DMA. $1.25 may be in play.
Jane Street trading in NWBO. Not huge, but why are they in the stock? Dumping for someone? Buying for someone?
NWBO Monthly Trades
January JANE STREET CAPITAL, LLC 1,185,562
December JANE STREET CAPITAL, LLC 1,822,232
November JANE STREET CAPITAL, LLC 2,666,219
October JANE STREET CAPITAL, LLC 301,767
September JANE STREET CAPITAL, LLC 0
Feb-August JANE STREET CAPITAL, LLC 0
(JANE) Jane Street capital usually does not dabble in OTC trading from what I see. They only came into NWBO in October. I looked back from June to September 2020 and they had no trading volume in NWBO.
50DMA became resistance Friday and we couldn't get back through. Now we are sitting on the 100DMA. If that doesn't hold, $1.25 is back in play as next support. frustrating.
Someone is dumping shares again, is it you?
looks like another selling pressure opening.
BTW, I emailed DI about Cognate and asked if there were any restrictions or clawback relating to Cognate 12 million NWBO shares upon a sale. And, would this sale warrant a PR commenting on the sale and any potential contract implications. No reply, I thought a fair question.
Oct 5th PR said Topline and Publication. Nothing new, IMO.
No chance in the world we are still blinded. The outside statisticians merely compile the data into the tables per the SAP. It's 331 patients, many of whom the data is minimal based on survival. Impossible it would take this long. They work on computers from home, like everyone else so no covid delays on this part, IMO.
low volume sell off as we have seen in the past. Could be warrant conversion/sale. Could be frustrated longs. Who knows. There isn't enough exposure for this stock to generate consistent buyer interest. So, those who are and have been long have to ride the wave of PPS amid the silence. That's the frustration I have with mgmt. They believe their path is the best. I have disagreed all along and still do. The fact that we have literally zero idea when topline will come is unfrickinbelievable to me.
I asked DI if there would be any comment on the Cognate deal and no reply. Asked if there is a material impact on our deal/relationship with them. Asked if it impacted Sawston in any way. Nothing.
I'm well aware of the "wait forever" group and the "no news is good news" group. And definitely aware of the "I know more than you so shut up" group.
Unfortunately, DI is in ALL of those groups so you wait, or you sell.
Nice rose-colored glasses. The truth is that shareholders have a right to know what is going on with this company. It is bullshit that they are referring back to an Oct. 5th PR which has no timeline for topline. That is after all statements of topline by September 30th. 4 and a half months is ridiculous.
Please. We don't need this type of posting without real link or back up.
Has anyone reached out to DI regarding Sawston DCVax-L production? Or about this Cognate deal? Or, anything else?
I don't think the sale was related to NWBO, unless the acquirer sees the potential. And, apparently they do to pay $875M for a relative start-up, revenue-wise.
Might the Cognate deal require a PR from NWBO to discuss any impact on our contract or relationship?
That is a VERY interesting point and I never put those two ideas together. Since the company is unblinded and preparing topline release, they could have huge liability if they were offering the treatment in the U.K. knowing full well it wouldn't help. So, since they continue to offer treatment, it has to be a validation of the science and efficacy. Right?
Fairly decent and recent UK Specials Info from 2019:
https://brainstrust.org.uk/wp-content/uploads/2019/03/brainstrust-know-hows-immunotherapy-10.02.19-1.pdf
Yes, UK Specials Program.
This would be a great week to announce topline. 4 and 1/2 months from data lock is enough to analyze, secure a Journal, and release. Let's Go!
Last year they announced ASM on Feb 18th for April 18th. Could do the same this week. Last year was the first year they moved it to later in the year.
I believe we will get announcement this week for ASM in late April. If so, I then think that sets the time frame for topline PR. LP will not have an ASM with an ask to raise authorized shares without topline first. Timing ASM to topline is important, IMO. And, the journal is the only wrench in the works to scheduling ASM and topline. Will be telling, IMO.
LOL. Well, there is a standing 100 share offer than we can't seem to get through. Wouldn't make me think we are getting a power hour.
From whom? And When?
Bouncing within the $1.50 and $1.65 range. $1.50 is pretty strong support and 50DMA is right below that. May see an attempted shakeout but doubt it goes below $1.50. Unfortunately there isn't enough buying conviction to get us through resistance. On the other hand, there isn't enough selling to move us lower. Treading water until news. Pretty boring.
For those who care, I did get a quick response from DI yesterday. I asked if the ASM would be on the same timeframe as last year. Meaning mid-February announcement and mid April ASM. I was hoping to try to back into the topline release as I believe it will come before ASM. He replied that "it hasn't been decided that I know of."
There are a lot of medical and medical research backgrounds who post here debating, and mostly validating the prospects of the science. In my 6 yrs in this stock I have learned more about GBM and immunotherapy than most people on earth know, IMOHO. A lot from posters and then from my own DD.
Welcome. Lots of questions and too long of a story to tell on this board. Yes, the science is solid. Yes, it could be game-changing. There are a lot of knowledgeable posters here with backgrounds fit to comment. Price per share is a a result of a combination of FUDs, shorts, NWBO mgmt silence/missteps. SO, it is a waiting game that I feel will result in rich rewards.
If we hold and finish toward the HOD it would be a nice hammer candlestick for tomorrow!